Shuttle Pharmaceuticals Holdings, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for SHPH, updated each market day.
SHPH AI Sentiment
AI predicts Shuttle Pharmaceuticals Holdings, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Shuttle Pharmaceuticals Holdings, Inc. Common Stock
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
Sector
Exchange
Market Cap
$4,054,244
Cap Tier
Employees
2
Headquarters
GAITHERSBURG, MD
Listed Since
Aug. 31, 2022
Website
SHPH Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
SHPH Volatility
Shuttle Pharmaceuticals Holdings, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
